Moreover, CD19+ cells isolated from peripheral blood (PB) of ACPA-positive early RA patients show higher expression of miR-155 then ACPA-positive LSRA patients (P=0.002, Mann-Whitney U-test) (Fig. 2c). The gene discussed is CD19; the disease is rheumatoid arthritis.